基本信息
浏览量:407
职业迁徙
个人简介
Prof. Hiltrud Brauch came to the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP) in 1999 after completing her training in Molecular Genetics of Cancer and Habilitation in the field of Molecular Pathology. She has held positions of increasing responsibility at the National Cancer Institute (NCI), USA, the German Cancer Research Center, Heidelberg, the Technical University Munich (Klinikum rechts der Isar), the University of Hamburg, and the IKP Stuttgart.
During her postdoctoral training at the NCI, she was part of the team identifying the VHL Tumor Suppressor Locus and since then pursues a range of scientific interests including the Molecular Origin of Hereditary (VHL disease) and Sporadic Kidney Cancer. Within the last decade she has established a reputation within the field of Breast Cancer Susceptibility and Treatment Outcomes. At IKP she has expanded her research towards a strong focus on the Pharmacogenomics of Breast Cancer.
Prof. Brauch participates in a number of national and international research networks including the Gene Environment Interactions and Breast Cancer in Germany (GENICA), the Breast Cancer Association Consortium (BCAC) and the International Tamoxifen Consortium (ITPC). She coordinated the 5FP EU European Marie Curie PhD training site Stuttgart/Tübingen “Fighting Breast Cancer”, and teaches at the University of Tübingen. Currently she coordinates the 7FP EU Initial Training Network Fighting Drug Failure, which establishes the first European Curriculum in the field of Pharmacogenomics for young investigators.
Scientific accomplishments include more than 150 peer reviewed publications, including more than 220 original research articles.
During her postdoctoral training at the NCI, she was part of the team identifying the VHL Tumor Suppressor Locus and since then pursues a range of scientific interests including the Molecular Origin of Hereditary (VHL disease) and Sporadic Kidney Cancer. Within the last decade she has established a reputation within the field of Breast Cancer Susceptibility and Treatment Outcomes. At IKP she has expanded her research towards a strong focus on the Pharmacogenomics of Breast Cancer.
Prof. Brauch participates in a number of national and international research networks including the Gene Environment Interactions and Breast Cancer in Germany (GENICA), the Breast Cancer Association Consortium (BCAC) and the International Tamoxifen Consortium (ITPC). She coordinated the 5FP EU European Marie Curie PhD training site Stuttgart/Tübingen “Fighting Breast Cancer”, and teaches at the University of Tübingen. Currently she coordinates the 7FP EU Initial Training Network Fighting Drug Failure, which establishes the first European Curriculum in the field of Pharmacogenomics for young investigators.
Scientific accomplishments include more than 150 peer reviewed publications, including more than 220 original research articles.
研究兴趣
论文共 428 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
引用0浏览0WOS引用
0
0
crossref(2023)
Clinical Pharmacology & Therapeuticsno. 3 (2023): 712-723
引用4浏览0引用
4
0
European journal of epidemiologyno. 10 (2023): 1053-1068
Helen Warren,Frank Dudbridge,Olivia Fletcher,Nick Orr,Nichola Johnson,John L. Hopper,Carmel Apicella,Melissa C. Southey, Maryam Mahmoodi,Marjanka K. Schmidt,Annegien Broeks,Sten Cornelissen,
crossref(2023)
Kristen N. Stevens, Zachary Fredericksen,Celine M. Vachon,Xianshu Wang,Sara Margolin,Annika Lindblom,Heli Nevanlinna,Dario Greco, Kristiina Aittomäki,Carl Blomqvist,Jenny Chang-Claude,Alina Vrieling,
crossref(2023)
crossref(2023)
crossref(2023)
Yuan Ji,Janet Olson, Jianping Zhang,Michelle Hildebrandt,Liewei Wang,James Ingle, Zachary Fredericksen,Thomas Sellers,William Miller,J. Michael Dixon,Hiltrud Brauch, Michel Eichelbaum,
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn